# M&T Bank Corp: overview

MTB · NYSE · CIK 36270 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtb.md) · [Financials](/companies/mtb/financials.md) · [Filings](/companies/mtb/filings.md) · [Insiders](/companies/mtb/insiders.md)

Latest reported revenue: [$442.0m](/filings/0000036270-26-000050.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000036270-26-000050).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [394](/filings/0000036270-25-000024.md) | [392 d](/filings/0000036270-26-000010.md) | [397](/filings/0000036270-26-000034.md) | [417](/filings/0000036270-26-000050.md) | [423](/filings/0000036270-25-000024.md) | [420 d](/filings/0000036270-26-000010.md) | [418](/filings/0000036270-26-000034.md) | [442](/filings/0000036270-26-000050.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [183.0%](/filings/0000036270-25-000024.md) | [173.7% d](/filings/0000036270-26-000010.md) | [147.1%](/filings/0000036270-26-000034.md) | [171.7%](/filings/0000036270-26-000050.md) | [187.2%](/filings/0000036270-25-000024.md) | [180.7% d](/filings/0000036270-26-000010.md) | [158.9%](/filings/0000036270-26-000034.md) | [185.1%](/filings/0000036270-26-000050.md) |
| Diluted EPS | $ per share | [4.02](/filings/0000036270-25-000024.md) | not reported | [3.32](/filings/0000036270-26-000034.md) | [4.24](/filings/0000036270-26-000050.md) | [4.82](/filings/0000036270-25-000024.md) | not reported | [4.13](/filings/0000036270-26-000034.md) | [5.32](/filings/0000036270-26-000050.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,992](/filings/0000950170-24-017990.md) | [1,525](/filings/0001628280-25-006267.md) | [1,484](/filings/0000036270-26-000010.md) | [1,541](/filings/0000036270-26-000010.md) | [1,657](/filings/0000036270-26-000010.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [31.0%](/filings/0000950170-24-017990.md) | [130.6%](/filings/0001628280-25-006267.md) | [184.7%](/filings/0000036270-26-000010.md) | [167.9%](/filings/0000036270-26-000010.md) | [172.1%](/filings/0000036270-26-000010.md) |
| Diluted EPS | $ per share | [13.80](/filings/0000950170-24-017990.md) | [11.53](/filings/0001628280-25-006267.md) | [15.79](/filings/0000036270-26-000010.md) | [14.64](/filings/0000036270-26-000010.md) | [17.00](/filings/0000036270-26-000010.md) |
| Free cash flow | $m | [2,566](/filings/0000950170-24-017990.md) | [4,360](/filings/0001628280-25-006267.md) | [3,649](/filings/0000036270-26-000010.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mtb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.06bn | 12,846,003 |  | Reduced −155,545 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $2.96bn | 12,417,262 |  | Reduced −754,074 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $2.33bn | 9,801,881 |  | Reduced −150,431 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.28bn | 9,566,754 |  | Reduced −211,907 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.69bn | 7,112,644 |  | Reduced −39,313 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.69bn | 7,080,537 |  | Reduced −408,000 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.03bn | 4,348,008 |  | Reduced −68,137 |
| [STATE FARM MUTUAL AUTOMOBILE INSURANCE CO](/funds/315032.md) | 2026-06-30 | $981.2m | 4,122,590 |  | Unchanged |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $967.8m | 4,045,990 |  | Added +41,761 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $958.0m | 4,025,037 |  | Added +23,113 |

## Recent filings

[All 3,759 filings](/companies/mtb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 10:02 ET | [8-K](/filings/0000036270-26-000057.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000036270-26-000057 |
| 2026-09-28 | 19:46 ET | [8-K](/filings/0000036270-26-000054.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000036270-26-000054 |
| 2026-09-22 | 21:22 ET | [8-K](/filings/0001193125-26-398138.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-398138 |
| 2026-09-14 | 20:24 ET | [8-K](/filings/0000036270-26-000052.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000036270-26-000052 |
| 2026-08-04 | 14:37 ET | [10-Q](/filings/0000036270-26-000050.md) | Quarterly report, period 2026-06-30 | 0000036270-26-000050 |
| 2026-07-21 | 20:36 ET | [8-K](/filings/0001193125-26-310413.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-310413 |
| 2026-07-15 | 10:02 ET | [8-K](/filings/0000036270-26-000046.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000036270-26-000046 |
| 2026-06-16 | 18:52 ET | [8-K](/filings/0000036270-26-000039.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000036270-26-000039 |
| 2026-05-05 | 15:33 ET | [10-Q](/filings/0000036270-26-000034.md) | Quarterly report, period 2026-03-31 | 0000036270-26-000034 |
| 2026-05-01 | 20:05 ET | [8-K](/filings/0000036270-26-000030.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000036270-26-000030 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000036270-26-000010.md), filed Feb 18, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 36270
- Tickers: MTB, MTB-PH, MTB-PJ, MTB-PK, MTB-PL
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: NY
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.